PCH
COGT icon

Polar Capital Holdings’s Cogent Biosciences COGT Stock Holding History

Polar Capital Holdings’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125M Buy
+3,232,905
New +$113M 0.3% 71
2021
Q4 		– Sell
-1,228,828
Closed -$10.3M – 450
2021
Q3 		$10.3M Buy
1,228,828
+228,828
+23% +$1.75M 0.04% 228
2021
Q2 		$8.11M Hold
1,000,000
– – 0.04% 246
2021
Q1 		$8.78M Sell
1,000,000
-189,900
-16% -$1.83M 0.05% 219
2020
Q4 		$13.4M Buy
+1,189,900
New +$13.1M 0.08% 187

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Polar Capital Holdings's COGT Position: Q2 2026 in Review

Polar Capital Holdings opened a new position in Cogent Biosciences (COGT) in Q2 2026: 3,232,905 shares worth $125M. The stake represents 0.3% of the portfolio and ranks #71 among its holdings. This is a return to the name: Polar Capital Holdings previously reported a position in COGT as recently as Q3 2021.

Polar Capital Holdings first reported a position in COGT in Q4 2020 and has held it in 5 quarters since. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Polar Capital Holdings held 3,232,905 shares of Cogent Biosciences worth $125M as of Q2 2026.
  • Cogent Biosciences was a new Polar Capital Holdings position in Q2 2026.
  • Cogent Biosciences made up 0.3% of Polar Capital Holdings's portfolio in Q2 2026, its #71 holding.
  • Polar Capital Holdings first reported a position in Cogent Biosciences in Q4 2020 and has held it in 5 quarters since.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.